MXHN Max Automation SE

DGAP-News: MA micro automation GmbH, a subsidiary of MAX Automation SE, receives major order from the medical technology sector

DGAP-News: MAX Automation SE / Key word(s): Incoming Orders
MA micro automation GmbH, a subsidiary of MAX Automation SE, receives major order from the medical technology sector
09.12.2019 / 07:30
The issuer is solely responsible for the content of this announcement.


PRESS RELEASE

MA micro automation GmbH, a subsidiary of MAX Automation SE, receives major order from the medical technology sector

Duesseldorf, 9 December 2019 - MA micro automation GmbH (MA micro), a subsidiary of MAX Automation SE, listed in the Prime Standard of the German Stock Exchange, announces a new major order. For a customer in the medical technology sector, the special machine builder will build assembly machines for medical optical systems. The order from the USA has a total volume in the low double-digit million Euro range.

The company based in St. Leon-Rot near Heidelberg with more than 170 employees is one of the leading international companies for automation solutions and special machine construction in the fields of medical technology and opto-electronic components. MA micro supplies the medical technology industry with production, testing and assembly systems for medical devices like contact lenses, diagnostic consumables, medical injection moulding components, inhalers, insulin pens, auto injectors as well as tips and cups.

The current major order is a further proof of the successful transformation process of MA micro - which is part of the Evolving Technologies business unit - towards the future market of medical technology and internationalization. "In 2013 the company was taken over by MAX Automation SE. Shortly afterwards, the strategic decision was made to focus the special machine manufacturer's activities on the field of medical technology. Now it is clear how successful and sustainable this strategy is, the new major order confirms that we will continue along this path", explains Dr. Guido Hild, head of the Evolving Technologies business unit and member of the Management Board of MAX Automation SE.

With its focus on medical technology, MA micro is active in a sustainably growing segment. Under the umbrella term "Lifescience", this area builds on global megatrends such as population growth and increasingly higher life expectancy. MA micro is ideally positioned here with its locations in Europe, Asia (Singapore) and North America (USA). It has a stable customer base. The demand for products covered by MA micro is growing dynamically. Due to its positioning, the company is optimistic about winning further major orders.

More information about MA micro automation can be found here:

 

Contact:

Katja Redweik
Head of Corporate Development/IR
MAX Automation SE
Tel.: 9 144

Contact for media representatives:

Susan Hoffmeister     Marco Cabras
CROSS ALLIANCE communication GmbH     newskontor - Agentur für Kommunikation
Phone: 09 03 33     Phone: 949 22
   
 


About MAX Automation SE
MAX Automation SE (ISIN DE000A2DA58), based in Dusseldorf, Germany, is an internationally active industrial group for high-tech automation solutions. The Group's operating business is divided into three segments: in its Process Technologies segment, the Group's comprehensive technological know-how makes it an innovation leader in the development and manufacture of proprietary solutions (e.g. dosing, impregnation), particularly for the automotive and electronics industries. MAX Automation's Environmental Technologies segment develops and installs technologically complex plants for the recycling, energy and raw materials industries. In its Evolving Technologies segment, MAX Automation bundles companies with growth potential in the fields of optical solutions, solutions for medical technology, industrial robotics and automation, as well as packaging solutions.



09.12.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: MAX Automation SE
Breite Straße 29-31
40213 Düsseldorf
Germany
Phone: +49 (0)211 90991-0
Fax: +49 (0)211 90991-11
E-mail:
Internet:
ISIN: DE000A2DA588
WKN: A2DA58
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 930849

 
End of News DGAP News Service

930849  09.12.2019 

fncls.ssp?fn=show_t_gif&application_id=930849&application_name=news&site_id=research_pool
EN
09/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Max Automation SE

MAX Automation SE: 1 director

A director at MAX Automation SE bought 300,000 shares at 4.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

EQS-News: MAX Automation SE concludes new syndicated loan agreement ah...

EQS-News: MAX Automation SE / Key word(s): Banking Syndicate/Financing MAX Automation SE concludes new syndicated loan agreement ahead of schedule with a volume of up to EUR 165 million 24.03.2025 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASEMAX Automation SE concludes new syndicated loan agreement ahead of schedule with a volume of up to EUR 165 million Hamburg, 24 March 2025 – MAX Automation SE, a company listed in the Prime Standard of the Frankfurt Stock Exchange (ISIN ), has taken out a new syndicated loan ahea...

 PRESS RELEASE

EQS-News: MAX Automation SE vereinbart vorzeitig neuen Konsortialkredi...

EQS-News: MAX Automation SE / Schlagwort(e): Bankenkonsortium/Finanzierung MAX Automation SE vereinbart vorzeitig neuen Konsortialkredit mit einem Volumen von bis zu 165 Mio. Euro 24.03.2025 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNGMAX Automation SE vereinbart vorzeitig neuen Konsortialkredit mit einem Volumen von bis zu 165 Mio. Euro Hamburg, 24. März 2025 – Die im Prime Standard der Frankfurter Wertpapierbörse notierte MAX Automation SE (ISIN ) hat unter Konsortialführung der Commerzbank mit ihren lan...

 PRESS RELEASE

EQS-News: MAX Automation SE continues to perform resiliently in a chal...

EQS-News: MAX Automation SE / Key word(s): Annual Report/Annual Results MAX Automation SE continues to perform resiliently in a challenging financial year 2024 by posting a positive result 20.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE MAX Automation SE continues to perform resiliently in a challenging financial year 2024 by posting a positive result   Sales from continuing operations decline to EUR 366.0 million (12M 2023: EUR 397.4 million) due to continued muted demand Operating result (EBITDA) from c...

 PRESS RELEASE

EQS-News: MAX Automation SE zeigt sich mit positivem Ergebnis weiterhi...

EQS-News: MAX Automation SE / Schlagwort(e): Jahresbericht/Jahresergebnis MAX Automation SE zeigt sich mit positivem Ergebnis weiterhin widerstandsfähig im herausfordernden Geschäftsjahr 2024 20.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNG MAX Automation SE zeigt sich mit positivem Ergebnis weiterhin widerstandsfähig im herausfordernden Geschäftsjahr 2024   Umsatz der fortgeführten Geschäftsbereiche sinkt aufgrund weiter zurückhaltender Nachfrage auf 366,0 Mio. Euro (12M 2023: 397,4 Mio. Euro) Op...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch